2003-2011 Yillari Arasinda Meram Tip Fakültesi Organ Nakli Merkezinde Yapilan Böbrek Nakli Olgularinin Sonuçlari

Translated title of the contribution: Renal transplant results of the organ transplant center of meram medical school between 2003-2011

Kültigin Türkmen, Fatih Mehmet Erdur, Mehmet Erikoǧlu, Abduzhappar Gaipov, Bayram Çolak, Ahmet Tekin, Mehdi Yeksan, Nedim Yilmaz Selçuk, Süleyman Türk, Şakir Tavli, Halil Zeki Tonbul

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVE: Renal transplantation (RTx) is the best therapeutic modality for end-stage renal disease patients. We report 8 years single-centre experience on cadaveric and living donor RTx in terms of demographic features along with graft functions, posttransplant medical complications, patients-graft survivals. MATERIAL and METHODS: We enrolled 66 RTx (female/male: 36/30) patients including 40 cadaveric and 26 living donors. At admission age, gender, causes of renal failure, dialysis typeduration, type of RTx, induction and maintenance immunosuppressive modalities, rejection episodes, biochemistry-hemogram parameters at 1, 6, 12, 24 and 60 months after transplantation and medical complications were obtained from the medical records. RESULTS: Mean recipient age was 41±11.6 years. Mean transplant duration was 32.2±31.4 months, and the mean creatinine values was 1.4±0.9 mg/dl. The most commonly used immunosuppressive protocol was corticosteroid+tacrolimus+mycophenolate mofetil. Delayed graft function, chronic allograft nephropathy and acute rejection were observed in 27.3%, 25.7% and 13.6% of patients, respectively. 1- and 5-year patient survival rates were 100% and 100% for living donor patients and and 80% for cadaveric RTx patients, respectively. The most common medical complications were new onset diabetes mellitus and dyslipidemia. The most common early and late infection was urinary tract infection. CONCLUSION: RTx is the best renal replacement therapy in terms of patient-graft survival. However, patients should be closely moniterized for metabolic complications.

Original languageTurkish
Pages (from-to)34-44
Number of pages11
JournalTurkish Nephrology, Dialysis and Transplantation Journal
Volume22
Issue number1
DOIs
StatePublished - Feb 15 2013

Fingerprint

Medical Schools
Transplants
Kidney
Living Donors
Graft Survival
Immunosuppressive Agents
Delayed Graft Function
Mycophenolic Acid
Renal Replacement Therapy
Tacrolimus
Dyslipidemias
Urinary Tract Infections
Biochemistry
Kidney Transplantation
Chronic Kidney Failure
Medical Records
Renal Insufficiency
Allografts
Renal Dialysis
Creatinine

All Science Journal Classification (ASJC) codes

  • Surgery
  • Urology

Cite this

2003-2011 Yillari Arasinda Meram Tip Fakültesi Organ Nakli Merkezinde Yapilan Böbrek Nakli Olgularinin Sonuçlari. / Türkmen, Kültigin; Erdur, Fatih Mehmet; Erikoǧlu, Mehmet; Gaipov, Abduzhappar; Çolak, Bayram; Tekin, Ahmet; Yeksan, Mehdi; Selçuk, Nedim Yilmaz; Türk, Süleyman; Tavli, Şakir; Tonbul, Halil Zeki.

In: Turkish Nephrology, Dialysis and Transplantation Journal, Vol. 22, No. 1, 15.02.2013, p. 34-44.

Research output: Contribution to journalArticle

Türkmen, K, Erdur, FM, Erikoǧlu, M, Gaipov, A, Çolak, B, Tekin, A, Yeksan, M, Selçuk, NY, Türk, S, Tavli, Ş & Tonbul, HZ 2013, '2003-2011 Yillari Arasinda Meram Tip Fakültesi Organ Nakli Merkezinde Yapilan Böbrek Nakli Olgularinin Sonuçlari', Turkish Nephrology, Dialysis and Transplantation Journal, vol. 22, no. 1, pp. 34-44. https://doi.org/10.5262/tndt.2013.1001.05
Türkmen, Kültigin ; Erdur, Fatih Mehmet ; Erikoǧlu, Mehmet ; Gaipov, Abduzhappar ; Çolak, Bayram ; Tekin, Ahmet ; Yeksan, Mehdi ; Selçuk, Nedim Yilmaz ; Türk, Süleyman ; Tavli, Şakir ; Tonbul, Halil Zeki. / 2003-2011 Yillari Arasinda Meram Tip Fakültesi Organ Nakli Merkezinde Yapilan Böbrek Nakli Olgularinin Sonuçlari. In: Turkish Nephrology, Dialysis and Transplantation Journal. 2013 ; Vol. 22, No. 1. pp. 34-44.
@article{656c994645da4f6abf441740e97e13ee,
title = "2003-2011 Yillari Arasinda Meram Tip Fak{\"u}ltesi Organ Nakli Merkezinde Yapilan B{\"o}brek Nakli Olgularinin Sonu{\cc}lari",
abstract = "OBJECTIVE: Renal transplantation (RTx) is the best therapeutic modality for end-stage renal disease patients. We report 8 years single-centre experience on cadaveric and living donor RTx in terms of demographic features along with graft functions, posttransplant medical complications, patients-graft survivals. MATERIAL and METHODS: We enrolled 66 RTx (female/male: 36/30) patients including 40 cadaveric and 26 living donors. At admission age, gender, causes of renal failure, dialysis typeduration, type of RTx, induction and maintenance immunosuppressive modalities, rejection episodes, biochemistry-hemogram parameters at 1, 6, 12, 24 and 60 months after transplantation and medical complications were obtained from the medical records. RESULTS: Mean recipient age was 41±11.6 years. Mean transplant duration was 32.2±31.4 months, and the mean creatinine values was 1.4±0.9 mg/dl. The most commonly used immunosuppressive protocol was corticosteroid+tacrolimus+mycophenolate mofetil. Delayed graft function, chronic allograft nephropathy and acute rejection were observed in 27.3{\%}, 25.7{\%} and 13.6{\%} of patients, respectively. 1- and 5-year patient survival rates were 100{\%} and 100{\%} for living donor patients and and 80{\%} for cadaveric RTx patients, respectively. The most common medical complications were new onset diabetes mellitus and dyslipidemia. The most common early and late infection was urinary tract infection. CONCLUSION: RTx is the best renal replacement therapy in terms of patient-graft survival. However, patients should be closely moniterized for metabolic complications.",
author = "K{\"u}ltigin T{\"u}rkmen and Erdur, {Fatih Mehmet} and Mehmet Erikoǧlu and Abduzhappar Gaipov and Bayram {\cC}olak and Ahmet Tekin and Mehdi Yeksan and Sel{\cc}uk, {Nedim Yilmaz} and S{\"u}leyman T{\"u}rk and Şakir Tavli and Tonbul, {Halil Zeki}",
year = "2013",
month = "2",
day = "15",
doi = "10.5262/tndt.2013.1001.05",
language = "Turkish",
volume = "22",
pages = "34--44",
journal = "Turkish Nephrology, Dialysis and Transplantation Journal",
issn = "1300-7718",
publisher = "Turkish society of Nephrology",
number = "1",

}

TY - JOUR

T1 - 2003-2011 Yillari Arasinda Meram Tip Fakültesi Organ Nakli Merkezinde Yapilan Böbrek Nakli Olgularinin Sonuçlari

AU - Türkmen, Kültigin

AU - Erdur, Fatih Mehmet

AU - Erikoǧlu, Mehmet

AU - Gaipov, Abduzhappar

AU - Çolak, Bayram

AU - Tekin, Ahmet

AU - Yeksan, Mehdi

AU - Selçuk, Nedim Yilmaz

AU - Türk, Süleyman

AU - Tavli, Şakir

AU - Tonbul, Halil Zeki

PY - 2013/2/15

Y1 - 2013/2/15

N2 - OBJECTIVE: Renal transplantation (RTx) is the best therapeutic modality for end-stage renal disease patients. We report 8 years single-centre experience on cadaveric and living donor RTx in terms of demographic features along with graft functions, posttransplant medical complications, patients-graft survivals. MATERIAL and METHODS: We enrolled 66 RTx (female/male: 36/30) patients including 40 cadaveric and 26 living donors. At admission age, gender, causes of renal failure, dialysis typeduration, type of RTx, induction and maintenance immunosuppressive modalities, rejection episodes, biochemistry-hemogram parameters at 1, 6, 12, 24 and 60 months after transplantation and medical complications were obtained from the medical records. RESULTS: Mean recipient age was 41±11.6 years. Mean transplant duration was 32.2±31.4 months, and the mean creatinine values was 1.4±0.9 mg/dl. The most commonly used immunosuppressive protocol was corticosteroid+tacrolimus+mycophenolate mofetil. Delayed graft function, chronic allograft nephropathy and acute rejection were observed in 27.3%, 25.7% and 13.6% of patients, respectively. 1- and 5-year patient survival rates were 100% and 100% for living donor patients and and 80% for cadaveric RTx patients, respectively. The most common medical complications were new onset diabetes mellitus and dyslipidemia. The most common early and late infection was urinary tract infection. CONCLUSION: RTx is the best renal replacement therapy in terms of patient-graft survival. However, patients should be closely moniterized for metabolic complications.

AB - OBJECTIVE: Renal transplantation (RTx) is the best therapeutic modality for end-stage renal disease patients. We report 8 years single-centre experience on cadaveric and living donor RTx in terms of demographic features along with graft functions, posttransplant medical complications, patients-graft survivals. MATERIAL and METHODS: We enrolled 66 RTx (female/male: 36/30) patients including 40 cadaveric and 26 living donors. At admission age, gender, causes of renal failure, dialysis typeduration, type of RTx, induction and maintenance immunosuppressive modalities, rejection episodes, biochemistry-hemogram parameters at 1, 6, 12, 24 and 60 months after transplantation and medical complications were obtained from the medical records. RESULTS: Mean recipient age was 41±11.6 years. Mean transplant duration was 32.2±31.4 months, and the mean creatinine values was 1.4±0.9 mg/dl. The most commonly used immunosuppressive protocol was corticosteroid+tacrolimus+mycophenolate mofetil. Delayed graft function, chronic allograft nephropathy and acute rejection were observed in 27.3%, 25.7% and 13.6% of patients, respectively. 1- and 5-year patient survival rates were 100% and 100% for living donor patients and and 80% for cadaveric RTx patients, respectively. The most common medical complications were new onset diabetes mellitus and dyslipidemia. The most common early and late infection was urinary tract infection. CONCLUSION: RTx is the best renal replacement therapy in terms of patient-graft survival. However, patients should be closely moniterized for metabolic complications.

UR - http://www.scopus.com/inward/record.url?scp=84873602902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873602902&partnerID=8YFLogxK

U2 - 10.5262/tndt.2013.1001.05

DO - 10.5262/tndt.2013.1001.05

M3 - Article

VL - 22

SP - 34

EP - 44

JO - Turkish Nephrology, Dialysis and Transplantation Journal

JF - Turkish Nephrology, Dialysis and Transplantation Journal

SN - 1300-7718

IS - 1

ER -